NVUS - Novus Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue---2,715
Gross Profit----2,715
Operating Expenses
Research Development6,8172,0223,1913,191
Selling General and Administrative7,24311,0991,9371,474
Non Recurring----
Total Operating Expenses14,06013,1215,1284,189
Operating Income or Loss-14,060-13,121-5,128-4,189
Income from Continuing Operations
Total Other Income/Expenses Net-55-527-25
Earnings Before Interest and Taxes-14,060-13,121-5,128-4,189
Interest Expense----
Income Before Tax-14,065-13,116-5,655-4,214
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-14,065-13,116-5,655-4,214
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-14,065-13,116-5,655-4,214
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-14,065-10,778-941-687